MYC and cervical cancer: Similarly, HPV18 has been found to be integrated downstream, upstream (at POU5F1B and OCT4) or within MYC, resulting in its amplification (20 fold) and over-expression (4.3-fold induced) in cervical cancers [56, 71, 73].